Literature DB >> 26929419

Paediatric respiratory infections.

Mark L Everard1.   

Abstract

Pulmonary infections remain a major cause of infant and child mortality worldwide and are responsible for a substantial burden of morbidity. During the 2015 European Respiratory Society International Congress in Amsterdam, some of the main findings from peer-reviewed articles addressing this topic that were published in the preceding 12 months were reviewed in a Paediatric Clinical Year in Review session. The following article highlights some of the insights provided by these articles into the complex interactions of the human host with the extensive and dynamic populations of microorganisms that call an individual "home".
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 26929419     DOI: 10.1183/16000617.0084-2015

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  10 in total

1.  Impact of Rapid Molecular Detection of Respiratory Viruses on Clinical Outcomes and Patient Management.

Authors:  Jane Kuypers
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 2.  Impact of nasopharyngeal microbiota on the development of respiratory tract diseases.

Authors:  S Esposito; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-09       Impact factor: 3.267

3.  Positive bronchoalveolar lavage pepsin assay associated with viral and fungal respiratory infections in children with chronic cough.

Authors:  Corey N Martin; Zhour Barnawi; Elizabeth Chorvinsky; Dhruv Pillai; Meagan Gatti; Maura E Collins; Gina M Krakovsky; Nancy M Bauman; Sona Sehgal; Dinesh K Pillai
Journal:  Pediatr Pulmonol       Date:  2021-05-13

Review 4.  Key paediatric messages from the 2017 European Respiratory Society International Congress.

Authors:  Jonathan Grigg; Jürg Barben; Mark L Everard; Graham Hall; Bülent Karadag; Alexander Moeller; Raffaella Nenna; Kostas N Priftis; Robbert J Rottier; Suzanne W J Terheggen-Lagro; Fabio Midulla
Journal:  ERJ Open Res       Date:  2018-05-25

Review 5.  Multiplex Platforms for the Identification of Respiratory Pathogens: Are They Useful in Pediatric Clinical Practice?

Authors:  Susanna Esposito; Antonella Mencacci; Elio Cenci; Barbara Camilloni; Ettore Silvestri; Nicola Principi
Journal:  Front Cell Infect Microbiol       Date:  2019-06-04       Impact factor: 5.293

6.  Contributing to a better understanding of infectious respiratory diseases in Mozambique.

Authors:  Tufária Mussá
Journal:  EBioMedicine       Date:  2020-11-21       Impact factor: 8.143

7.  Epidemiology of Respiratory Pathogens in Children with Severe Acute Respiratory Infection and Impact of the Multiplex PCR Film Array Respiratory Panel: A 2-Year Study.

Authors:  Asmae Lamrani Hanchi; Morad Guennouni; Meriem Rachidi; Toufik Benhoumich; Hind Bennani; Mounir Bourrous; Fadl Mrabih Rabou Maoulainine; Said Younous; Mohamed Bouskraoui; Nabila Soraa
Journal:  Int J Microbiol       Date:  2021-12-31

8.  Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.

Authors:  Pan Fu; Hongmei Xu; Chunmei Jing; Jikui Deng; Hongmei Wang; Chunzhen Hua; Yinghu Chen; Xuejun Chen; Ting Zhang; Hong Zhang; Yiping Chen; Jinhong Yang; Aiwei Lin; Shifu Wang; Qing Cao; Xing Wang; Huiling Deng; Sancheng Cao; Jianhua Hao; Wei Gao; Yuanyuan Huang; Hui Yu; Chuanqing Wang
Journal:  Microbiol Spectr       Date:  2021-11-03

Review 9.  Microfluidic lumen-based systems for advancing tubular organ modeling.

Authors:  María Virumbrales-Muñoz; José M Ayuso; Max M Gong; Mouhita Humayun; Megan K Livingston; Karina M Lugo-Cintrón; Patrick McMinn; Yasmín R Álvarez-García; David J Beebe
Journal:  Chem Soc Rev       Date:  2020-09-01       Impact factor: 60.615

10.  Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner.

Authors:  Zhaoche Shu; Jun Yuan; Hong Wang; Jinghui Zhang; Sijie Li; Hong Zhang; Yusi Liu; Yibing Yin; Xuemei Zhang
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.